Greg Bradley - Apr 10, 2023 Form 4 Insider Report for Petros Pharmaceuticals, Inc. (PTPI)

Role
Director
Signature
/s/ Mitchell Arnold, attorney-in-fact
Stock symbol
PTPI
Transactions as of
Apr 10, 2023
Transactions value $
$0
Form type
4
Date filed
4/12/2023, 06:00 PM
Previous filing
Jan 25, 2023
Next filing
Apr 28, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PTPI Stock Option (Right to Buy) Award $0 +39K $0.00 39K Apr 10, 2023 Common Stock 39K $0.99 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options will vest on the one-year anniversary of the date of grant, provided that the Reporting Person has continued to provide services to Petros Pharmaceuticals, Inc. (the "Company") through the vesting date.